REFERENCES
- Bühler V. Kollidon®, Polyvinylpyrrolidone for the Pharmaceutical Industry. Aktiengesellschaft Feinchemie D-67056, Ludwigshafen 1993
- Walkling W. D. Handbook of Pharmaceutical Excipients, A. Wade, P. J. Weller. The Pharm. Press, London 1994; 392–399
- Ford J. L. Pharm. Acta Helv. 1986; 61: 69–88
- Hamza Y. E., Sammour O. A., Abdel-Latif H. A. Pharm. Ind. 1994; 56: 286–291
- Shiraeff D. A. JAOAC 1964; 47: 724–730
- Frauenfelder L. J. JAOAC 1974; 57: 796–800
- Ericsson I., Ljunggren L. J. Anal. Appl. Pyrolysis 1990; 17: 251–260
- Ziller K. H., Rupprecht H. Arch. Pharm. 1981; 314: 970–972
- Ridgway K., Rubinstein M. H. J. Pharm. Pharmacol. 1971; 23: 587–589
- Levy G. B., Fergus D. Anal. Chem. 1953; 25: 1408–1410
- Chinard F. P. J. Lab. Clin. Med. 1952; 39: 666–672
- Pedersen G. P., Kristensen H. G. 14th Pharmaceutical Technology Conference. BarcelonaSpain, North Liverpool, UK 1995; III: 15–32
- Adams M. J. Chemometrics in Analytical Spectroscopy. The Royal Society of Chemistry, Cambridge 1995; 155–203
- Schmidt P. C., Glombitza B. W. Trends Anal. Chem. 1995; 14: 45–49
- European Pharmacopoeia. 3rd ed., Council of Europe, StrassbourgFrance 1997
- Pharmeuropa, Technical Guide for the Elaboration of Monographs. 2nd ed., Council of Europe, StrasbourgFrance 1996